Literature DB >> 23776156

The RNase II/RNB family of exoribonucleases: putting the 'Dis' in disease.

Filipa P Reis1, Vânia Pobre, Inês J Silva, Michal Malecki, Cecília M Arraiano.   

Abstract

Important findings over the last years have shed new light onto the mechanistic details of RNA degradation by members of the RNase II/RNB family of exoribonucleases. Members of this family have been shown to be involved in growth, normal chloroplast biogenesis, mitotic control and cancer. Recently, different publications have linked human orthologs (Dis3 and Dis3L2) to important human diseases. This article describes the structural and biochemical characteristics of members of this family of enzymes, and the physiological implications that relate them with disease.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23776156     DOI: 10.1002/wrna.1180

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  17 in total

Review 1.  Regulation of RNA decay and cellular function by 3'-5' exoribonuclease DIS3L2.

Authors:  Siyu Luan; Junyun Luo; Hui Liu; Zhaoyong Li
Journal:  RNA Biol       Date:  2019-01-13       Impact factor: 4.652

2.  The RNase R from Campylobacter jejuni has unique features and is involved in the first steps of infection.

Authors:  Nabila Haddad; Rute G Matos; Teresa Pinto; Pauline Rannou; Jean-Michel Cappelier; Hervé Prévost; Cecília M Arraiano
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

3.  Yeast Ssd1 is a non-enzymatic member of the RNase II family with an alternative RNA recognition site.

Authors:  Rosemary A Bayne; Uma Jayachandran; Aleksandra Kasprowicz; Stefan Bresson; David Tollervey; Edward W J Wallace; Atlanta G Cook
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

4.  Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target.

Authors:  Rafal Tomecki; Karolina Drazkowska; Iwo Kucinski; Krystian Stodus; Roman J Szczesny; Jakub Gruchota; Ewelina P Owczarek; Katarzyna Kalisiak; Andrzej Dziembowski
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

5.  XRN1 stalling in the 5' UTR of Hepatitis C virus and Bovine Viral Diarrhea virus is associated with dysregulated host mRNA stability.

Authors:  Stephanie L Moon; Jeffrey G Blackinton; John R Anderson; Mary K Dozier; Benjamin J T Dodd; Jack D Keene; Carol J Wilusz; Shelton S Bradrick; Jeffrey Wilusz
Journal:  PLoS Pathog       Date:  2015-03-06       Impact factor: 6.823

6.  The 3'-5' exoribonuclease Dis3 regulates the expression of specific microRNAs in Drosophila wing imaginal discs.

Authors:  Benjamin P Towler; Christopher I Jones; Sandra C Viegas; Patricia Apura; Joseph A Waldron; Sarah K Smalley; Cecilia M Arraiano; Sarah F Newbury
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

7.  Structural insights into RNA unwinding and degradation by RNase R.

Authors:  Lee-Ya Chu; Tung-Ju Hsieh; Bagher Golzarroshan; Yi-Ping Chen; Sashank Agrawal; Hanna S Yuan
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

8.  Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product.

Authors:  Filipa P Reis; Ana Barbas; A A Klauer-King; Borislava Tsanova; Daneen Schaeffer; Eduardo López-Viñas; Paulino Gómez-Puertas; Ambro van Hoof; Cecília M Arraiano
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

Review 9.  The importance of proteins of the RNase II/RNB-family in pathogenic bacteria.

Authors:  Rute G Matos; Cátia Bárria; Ricardo N Moreira; Susana Barahona; Susana Domingues; Cecília M Arraiano
Journal:  Front Cell Infect Microbiol       Date:  2014-06-03       Impact factor: 5.293

Review 10.  Standing your ground to exoribonucleases: Function of Flavivirus long non-coding RNAs.

Authors:  Phillida A Charley; Jeffrey Wilusz
Journal:  Virus Res       Date:  2015-09-11       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.